Skip to main content
NCBI home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1996 May-Jun;69(3):289–300.

Is gastrinoma a medical disease?

M Mignon 1, G Cadiot 1, J P Marmuse 1, M J Lewin 1
PMCID: PMC2589009  PMID: 9165698

Abstract

Zollinger-Ellison syndrome (ZES) is a rare disease. Its management concerns symptoms related to the gastric acid overproduction that characterizes the syndrome and to the gastrin-producing tumor(s) usually located in the duodenal wall and/or the endocrine pancreas. Acid hypersecretion is now controlled by the use of powerful antisecretory agents. Management of the malignant process(es) has become the primary goal of modern strategy: it aims first at curing the disease and second at prolonging patient survival by prevention of hepatic metastasis. In patients with the sporadic form of the disease and without liver metastases, it is currently possible to localize and to surgically remove the endocrine tumor(s). This progress has been made feasible by refinements in modern medical imaging. At present, however, disease cure, even in the most favorable conditions, is not be greater than 30 to 50 percent at five years. In patients with ZES integrated in the context of multiple endocrine neoplasia type I, disease cure rate is extremely low, although occasional patient survival can be as good or even better than in the sporadic group. Disseminated malignancy (liver and/or extra-abdominal lymph nodes or bone localization) remains the principal determinant of early death. Surgical treatment is usually precluded in such cases. Liver transplantation has not been successful in these patients.

Full text

PDF
289

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonfils S., Landor J. H., Mignon M., Hervoir P. Results of surgical management in 92 consecutive patients with Zollinger-Ellison syndrome. Ann Surg. 1981 Dec;194(6):692–697. doi: 10.1097/00000658-198112000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cadiot G., Houillier P., Allouch A., Paillard M., Mignon M. Oral calcium tolerance test in the early diagnosis of primary hyperparathyroidism and multiple endocrine neoplasia type 1 in patients with the Zollinger-Ellison syndrome. Groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison. Gut. 1996 Aug;39(2):273–278. doi: 10.1136/gut.39.2.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cadiot G., Lebtahi R., Sarda L., Bonnaud G., Marmuse J. P., Vissuzaine C., Ruszniewski P., Le Guludec D., Mignon M. Preoperative detection of duodenal gastrinomas and peripancreatic lymph nodes by somatostatin receptor scintigraphy. Groupe D'etude Du Syndrome De Zollinger-Ellison. Gastroenterology. 1996 Oct;111(4):845–854. doi: 10.1016/s0016-5085(96)70052-5. [DOI] [PubMed] [Google Scholar]
  4. Creutzfeldt W., Bartsch H. H., Jacubaschke U., Stöckmann F. Treatment of gastrointestinal endocrine tumours with interferon-alpha and octreotide. Acta Oncol. 1991;30(4):529–535. doi: 10.3109/02841869109092413. [DOI] [PubMed] [Google Scholar]
  5. Ellison E. C., Carey L. C., Sparks J., O'Dorisio T. M., Mekhjian H. S., Fromkes J. J., Caldwell J. H., Thomas F. B. Early surgical treatment of gastrinoma. Am J Med. 1987 May 29;82(5B):17–24. doi: 10.1016/0002-9343(87)90423-2. [DOI] [PubMed] [Google Scholar]
  6. Fraker D. L., Norton J. A., Alexander H. R., Venzon D. J., Jensen R. T. Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma. Ann Surg. 1994 Sep;220(3):320–330. doi: 10.1097/00000658-199409000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fraker D. L., Norton J. A. The role of surgery in the management of islet cell tumors. Gastroenterol Clin North Am. 1989 Dec;18(4):805–830. [PubMed] [Google Scholar]
  8. Howard T. J., Sawicki M. P., Stabile B. E., Watt P. C., Passaro E., Jr Biologic behavior of sporadic gastrinoma located to the right and left of the superior mesenteric artery. Am J Surg. 1993 Jan;165(1):101–106. doi: 10.1016/s0002-9610(05)80411-8. [DOI] [PubMed] [Google Scholar]
  9. Jensen R. T., Fraker D. L. Zollinger-Ellison syndrome. Advances in treatment of gastric hypersecretion and the gastrinoma. JAMA. 1994 May 11;271(18):1429–1435. doi: 10.1001/jama.271.18.1429. [DOI] [PubMed] [Google Scholar]
  10. Makowka L., Tzakis A. G., Mazzaferro V., Teperman L., Demetris A. J., Iwatsuki S., Starzl T. E. Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas. Surg Gynecol Obstet. 1989 Feb;168(2):107–111. [PMC free article] [PubMed] [Google Scholar]
  11. Malagelada J. R., Edis A. J., Adson M. A., van Heerden J. A., Go V. L. Medical and surgical options in the management of patients with gastrinoma. Gastroenterology. 1983 Jun;84(6):1524–1532. [PubMed] [Google Scholar]
  12. McCarthy D. M. The place of surgery in the Zollinger-Ellison syndrome. N Engl J Med. 1980 Jun 12;302(24):1344–1347. doi: 10.1056/NEJM198006123022404. [DOI] [PubMed] [Google Scholar]
  13. Metz D. C., Kuchnio M., Fraker D. L., Venzon D. J., Jaffe G., Jensen R. T., Stetler-Stevenson M. Flow cytometry and Zollinger-Ellison syndrome: relationship to clinical course. Gastroenterology. 1993 Sep;105(3):799–813. doi: 10.1016/0016-5085(93)90898-m. [DOI] [PubMed] [Google Scholar]
  14. Mignon M., Ruszniewski P., Haffar S., Rigaud D., Rene E., Bonfils S. Current approach to the management of tumoral process in patients with gastrinoma. World J Surg. 1986 Aug;10(4):703–710. doi: 10.1007/BF01655562. [DOI] [PubMed] [Google Scholar]
  15. Mignon M., Ruszniewski P., Podevin P., Sabbagh L., Cadiot G., Rigaud D., Bonfils S. Current approach to the management of gastrinoma and insulinoma in adults with multiple endocrine neoplasia type I. World J Surg. 1993 Jul-Aug;17(4):489–497. doi: 10.1007/BF01655108. [DOI] [PubMed] [Google Scholar]
  16. Moertel C. G., Hanley J. A., Johnson L. A. Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma. N Engl J Med. 1980 Nov 20;303(21):1189–1194. doi: 10.1056/NEJM198011203032101. [DOI] [PubMed] [Google Scholar]
  17. Moertel C. G., Lefkopoulo M., Lipsitz S., Hahn R. G., Klaassen D. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma. N Engl J Med. 1992 Feb 20;326(8):519–523. doi: 10.1056/NEJM199202203260804. [DOI] [PubMed] [Google Scholar]
  18. Norton J. A., Doppman J. L., Collen M. J., Harmon J. W., Maton P. N., Gardner J. D., Jensen R. T. Prospective study of gastrinoma localization and resection in patients with Zollinger-Ellison syndrome. Ann Surg. 1986 Oct;204(4):468–479. doi: 10.1097/00000658-198610000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Norton J. A. Neuroendocrine tumors of the pancreas and duodenum. Curr Probl Surg. 1994 Feb;31(2):77–156. doi: 10.1016/0011-3840(94)90079-5. [DOI] [PubMed] [Google Scholar]
  20. Ruszniewski P., Amouyal P., Amouyal G., Grangé J. D., Mignon M., Bouché O., Bernades P. Localization of gastrinomas by endoscopic ultrasonography in patients with Zollinger-Ellison syndrome. Surgery. 1995 Jun;117(6):629–635. doi: 10.1016/s0039-6060(95)80005-0. [DOI] [PubMed] [Google Scholar]
  21. Ruszniewski P., Hochlaf S., Rougier P., Mignon M. Chimiothérapie intraveineuse par streptozotocine et 5 fluoro-uracile des métastases hépatiques du syndrome de Zollinger-Ellison. Etude prospective multicentrique chez 21 patients. Gastroenterol Clin Biol. 1991;15(5):393–398. [PubMed] [Google Scholar]
  22. Ruszniewski P., Podevin P., Cadiot G., Marmuse J. P., Mignon M., Vissuzaine C., Bonfils S., Lehy T. Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type I multiple endocrine neoplasia. Pancreas. 1993 May;8(3):295–304. doi: 10.1097/00006676-199305000-00003. [DOI] [PubMed] [Google Scholar]
  23. Ruszniewski P., Ramdani A., Cadiot G., Lehy T., Mignon M., Bonfils S. Long-term treatment with octreotide in patients with the Zollinger-Ellison syndrome. Eur J Clin Invest. 1993 May;23(5):296–301. doi: 10.1111/j.1365-2362.1993.tb00777.x. [DOI] [PubMed] [Google Scholar]
  24. Ruszniewski P., Rougier P., Roche A., Legmann P., Sibert A., Hochlaf S., Ychou M., Mignon M. Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients. Cancer. 1993 Apr 15;71(8):2624–2630. doi: 10.1002/1097-0142(19930415)71:8<2624::aid-cncr2820710830>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  25. Stabile B. E., Passaro E., Jr Benign and malignant gastrinoma. Am J Surg. 1985 Jan;149(1):144–150. doi: 10.1016/s0002-9610(85)80024-6. [DOI] [PubMed] [Google Scholar]
  26. Weber H. C., Venzon D. J., Lin J. T., Fishbein V. A., Orbuch M., Strader D. B., Gibril F., Metz D. C., Fraker D. L., Norton J. A. Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology. 1995 Jun;108(6):1637–1649. doi: 10.1016/0016-5085(95)90124-8. [DOI] [PubMed] [Google Scholar]
  27. de Kerviler E., Cadiot G., Lebtahi R., Faraggi M., Le Guludec D., Mignon M. Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome. GRESZE: Groupe d'Etude du Syndrome de Zollinger-Ellison. Eur J Nucl Med. 1994 Nov;21(11):1191–1197. doi: 10.1007/BF00182352. [DOI] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES